According to Zhitong Finance App News, Nanmo Biotech (688265.SH) released its 2026 semi-annual performance forecast. The company expects to achieve net profit of 8 million yuan to 10 million yuan in the half-year 2026, a year-on-year decrease of 44.96% to 55.97%. Net profit attributable to owners of the parent company is expected to be 13 million yuan to 15.8 million yuan for the semi-year 2026 after deducting the impact of share payments, an increase of 47.27% to 78.99% over the previous year.

Zhitongcaijing · 1d ago
According to Zhitong Finance App News, Nanmo Biotech (688265.SH) released its 2026 semi-annual performance forecast. The company expects to achieve net profit of 8 million yuan to 10 million yuan in the half-year 2026, a year-on-year decrease of 44.96% to 55.97%. Net profit attributable to owners of the parent company is expected to be 13 million yuan to 15.8 million yuan for the semi-year 2026 after deducting the impact of share payments, an increase of 47.27% to 78.99% over the previous year.